Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Affiliations

¹ Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
² Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
³ Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
⁴ University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
⁵ College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
⁶ Centre pour le Développement des Vaccins, Bamako, Mali.
⁷ INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
⁸ National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
⁹ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
¹⁰ Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
¹¹ London School of Hygiene & Tropical Medicine, London, UK.
¹² AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
¹³ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France. yazdan.yazdanpanah@aphp.fr.
¹⁴ AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France. yazdan.yazdanpanah@aphp.fr.

^# Contributed equally.

Published Erratum

Moses Badio et al. Trials. 2021.

. 2021 Sep 1;22(1):583.

doi: 10.1186/s13063-021-05572-3.

¹ Partnership for Research on Ebola Virus in Liberia (PREVAIL), Monrovia, Liberia.
² Univ. Bordeaux, Inserm, Bordeaux Population Health Research, Center, UMR 1219, CHU Bordeaux, CIC 1401, EUCLID/F-CRIN Clinical Trials Platform, F-33000, Bordeaux, France.
³ Centre National de Formation et de Recherche en Santé Rurale de Mafèrinyah, Mafèrinyah, Guinea.
⁴ University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
⁵ College of Medicine and Allied Health Sciences (COMAHS), University of Sierra Leone, Freetown, Sierra Leone.
⁶ Centre pour le Développement des Vaccins, Bamako, Mali.
⁷ INSERM, Pôle de Recherche Clinique, 75013, Paris, France.
⁸ National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
⁹ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France.
¹⁰ Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
¹¹ London School of Hygiene & Tropical Medicine, London, UK.
¹² AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France.
¹³ REACTing, Institut Thématique Immunologie, Inflammation, Infectiologie et Microbiologie, Inserm, Paris, France. yazdan.yazdanpanah@aphp.fr.
¹⁴ AP-HP, Hôpital Bichat-Claude Bernard, Service de Maladies Infectieuses et Tropicales, F-75018, Paris, France. yazdan.yazdanpanah@aphp.fr.

^# Contributed equally.

No abstract available

Erratum for

Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.
Badio M, Lhomme E, Kieh M, Beavogui AH, Kennedy SB, Doumbia S, Leigh B, Sow SO, Diallo A, Fusco D, Kirchoff M, Termote M, Vatrinet R, Wentworth D, Esperou H, Lane HC, Pierson J, Watson-Jones D, Roy C, D'Ortenzio E, Greenwood B, Chêne G, Richert L, Neaton JD, Yazdanpanah Y; PREVAC study team. Badio M, et al. Trials. 2021 Jan 23;22(1):86. doi: 10.1186/s13063-021-05035-9. Trials. 2021. PMID: 33485369 Free PMC article.

1. Badio, et al. Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries. Trials. 2021;22:86. doi: 10.1186/s13063-021-05035-9. - DOI - PMC - PubMed